Sun Pharma shares edge higher after prior 3% drop
Sun Pharmaceutical Industries shares edged higher in early trade on Sept. 2, stabilising after a nearly 3% fall in the prior session. Brokerages assessed the impact of its MFN pricing agreement with the US government.
Sun Pharmaceutical Industries shares edged higher in early trade on September 2, stabilising after a nearly 3 percent fall in the previous session, as brokerages assessed the impact of the drugmaker's Most Favored Nation (MFN) pricing agreement with the US government.The stock was trading 0.36 perc…